Kairos Pharma (KAPA) Goodwill & Intangibles (2023 - 2025)

Kairos Pharma (KAPA) has 3 years of Goodwill & Intangibles data on file, last reported at $62000.0 in Q4 2025.

• Quarterly Goodwill & Intangibles fell 72.07% year-over-year to $62000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $62000.0 (down 72.07% YoY) and the FY2025 annual result came in at $62000.0, down 72.07% from the prior year.
• Goodwill & Intangibles declined to $62000.0 in Q4 2025, from $142000.0 in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $382000.0 in Q4 2023 to a low of $62000.0 in Q4 2025.
• A 3-year average of $208666.7 and a median of $202000.0 in 2024 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2024 — Goodwill & Intangibles plunged 41.88% — and 2025, when it sank 72.07%.
• Tracing KAPA's Goodwill & Intangibles over 3 years: stood at $382000.0 in 2023, then sank by 41.88% to $222000.0 in 2024, then slumped by 72.07% to $62000.0 in 2025.
• The last three Goodwill & Intangibles figures came in at $62000.0 (Q4 2025), $142000.0 (Q2 2025), and $182000.0 (Q1 2025), per Business Quant data.